Glycosaminoglycan/chitosan hydrogel for matrix-associated autologous chondrocyte implantation

An in vitro study

Fang Yu Fan, Chien Chang Chiu, Ching Li Tseng, Hsuan Shu Lee, Yung Ning Pan, Kai Chiang Yang

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Matrix-associated autologous chondrocyte implantation (MACI) is an effective treatment for full-thickness cartilage and osteochondral lesions with encouraging outcomes. However, problems include abnormal growth of chondrocytes during cultivation, cell dedifferentiation, and abnormally regenerated cartilage. A matrix that provides a physicochemical and biological microenvironment for restoring hypertrophic chondrocytes would be beneficial for MACI. Accordingly, this study evaluates the feasibility of using an injectable glycosaminoglycan (GAG)/chitosan hydrogel for MACI. Chitosan gel was prepared and GAGs (hyaluronan and chondroitin-6-sulfate) were added to fabricate a GAG/chitosan matrix. Porcine chondrocytes were isolated from articular cartilage and encapsulated within the GAG/chitosan matrix. Cell viability, material-mediated cytotoxicity, cellular proliferation, collagen production, GAG content, and mRNA gene expression patterns of the chondrocytes were evaluated. The cell viability and material-mediated cytotoxicity assay results show that the GAG/chitosan hydrogel has good biocompatibility. Chondrocytes cultured within the matrix had a slower proliferation but higher GAG production compared to those obtained for a monolayer culture. Real-time polymerase chain reaction results show that the mRNA expression of type II collagen was up-regulated but types I and X collagens were down-regulated. This study demonstrates that incorporating GAGs into a chitosan matrix maintains the normal phenotype of chondrocytes, making the GAG/chitosan matrix a candidate for MACI.

Original languageEnglish
Pages (from-to)211-217
Number of pages7
JournalJournal of Medical and Biological Engineering
Volume34
Issue number3
DOIs
Publication statusPublished - 2014

Fingerprint

Hydrogel
Chitosan
Chondrocytes
Glycosaminoglycans
Hydrogels
Cartilage
Collagen
Cytotoxicity
Cells
Cell Survival
Polymerase chain reaction
Cell Dedifferentiation
Collagen Type X
In Vitro Techniques
Biocompatibility
Gene expression
Messenger RNA
Monolayers
Assays
Collagen Type II

Keywords

  • Autologous chondrocyte implantation
  • Chitosan hydrogel
  • Chondrocyte
  • Glycosaminoglycan

ASJC Scopus subject areas

  • Biomedical Engineering
  • Medicine(all)

Cite this

Glycosaminoglycan/chitosan hydrogel for matrix-associated autologous chondrocyte implantation : An in vitro study. / Fan, Fang Yu; Chiu, Chien Chang; Tseng, Ching Li; Lee, Hsuan Shu; Pan, Yung Ning; Yang, Kai Chiang.

In: Journal of Medical and Biological Engineering, Vol. 34, No. 3, 2014, p. 211-217.

Research output: Contribution to journalArticle

@article{116a536f52b64a6188bb09a418a52152,
title = "Glycosaminoglycan/chitosan hydrogel for matrix-associated autologous chondrocyte implantation: An in vitro study",
abstract = "Matrix-associated autologous chondrocyte implantation (MACI) is an effective treatment for full-thickness cartilage and osteochondral lesions with encouraging outcomes. However, problems include abnormal growth of chondrocytes during cultivation, cell dedifferentiation, and abnormally regenerated cartilage. A matrix that provides a physicochemical and biological microenvironment for restoring hypertrophic chondrocytes would be beneficial for MACI. Accordingly, this study evaluates the feasibility of using an injectable glycosaminoglycan (GAG)/chitosan hydrogel for MACI. Chitosan gel was prepared and GAGs (hyaluronan and chondroitin-6-sulfate) were added to fabricate a GAG/chitosan matrix. Porcine chondrocytes were isolated from articular cartilage and encapsulated within the GAG/chitosan matrix. Cell viability, material-mediated cytotoxicity, cellular proliferation, collagen production, GAG content, and mRNA gene expression patterns of the chondrocytes were evaluated. The cell viability and material-mediated cytotoxicity assay results show that the GAG/chitosan hydrogel has good biocompatibility. Chondrocytes cultured within the matrix had a slower proliferation but higher GAG production compared to those obtained for a monolayer culture. Real-time polymerase chain reaction results show that the mRNA expression of type II collagen was up-regulated but types I and X collagens were down-regulated. This study demonstrates that incorporating GAGs into a chitosan matrix maintains the normal phenotype of chondrocytes, making the GAG/chitosan matrix a candidate for MACI.",
keywords = "Autologous chondrocyte implantation, Chitosan hydrogel, Chondrocyte, Glycosaminoglycan",
author = "Fan, {Fang Yu} and Chiu, {Chien Chang} and Tseng, {Ching Li} and Lee, {Hsuan Shu} and Pan, {Yung Ning} and Yang, {Kai Chiang}",
year = "2014",
doi = "10.5405/jmbe.1516",
language = "English",
volume = "34",
pages = "211--217",
journal = "Journal of Medical and Biological Engineering",
issn = "1609-0985",
publisher = "中華民國生物醫學工程學會",
number = "3",

}

TY - JOUR

T1 - Glycosaminoglycan/chitosan hydrogel for matrix-associated autologous chondrocyte implantation

T2 - An in vitro study

AU - Fan, Fang Yu

AU - Chiu, Chien Chang

AU - Tseng, Ching Li

AU - Lee, Hsuan Shu

AU - Pan, Yung Ning

AU - Yang, Kai Chiang

PY - 2014

Y1 - 2014

N2 - Matrix-associated autologous chondrocyte implantation (MACI) is an effective treatment for full-thickness cartilage and osteochondral lesions with encouraging outcomes. However, problems include abnormal growth of chondrocytes during cultivation, cell dedifferentiation, and abnormally regenerated cartilage. A matrix that provides a physicochemical and biological microenvironment for restoring hypertrophic chondrocytes would be beneficial for MACI. Accordingly, this study evaluates the feasibility of using an injectable glycosaminoglycan (GAG)/chitosan hydrogel for MACI. Chitosan gel was prepared and GAGs (hyaluronan and chondroitin-6-sulfate) were added to fabricate a GAG/chitosan matrix. Porcine chondrocytes were isolated from articular cartilage and encapsulated within the GAG/chitosan matrix. Cell viability, material-mediated cytotoxicity, cellular proliferation, collagen production, GAG content, and mRNA gene expression patterns of the chondrocytes were evaluated. The cell viability and material-mediated cytotoxicity assay results show that the GAG/chitosan hydrogel has good biocompatibility. Chondrocytes cultured within the matrix had a slower proliferation but higher GAG production compared to those obtained for a monolayer culture. Real-time polymerase chain reaction results show that the mRNA expression of type II collagen was up-regulated but types I and X collagens were down-regulated. This study demonstrates that incorporating GAGs into a chitosan matrix maintains the normal phenotype of chondrocytes, making the GAG/chitosan matrix a candidate for MACI.

AB - Matrix-associated autologous chondrocyte implantation (MACI) is an effective treatment for full-thickness cartilage and osteochondral lesions with encouraging outcomes. However, problems include abnormal growth of chondrocytes during cultivation, cell dedifferentiation, and abnormally regenerated cartilage. A matrix that provides a physicochemical and biological microenvironment for restoring hypertrophic chondrocytes would be beneficial for MACI. Accordingly, this study evaluates the feasibility of using an injectable glycosaminoglycan (GAG)/chitosan hydrogel for MACI. Chitosan gel was prepared and GAGs (hyaluronan and chondroitin-6-sulfate) were added to fabricate a GAG/chitosan matrix. Porcine chondrocytes were isolated from articular cartilage and encapsulated within the GAG/chitosan matrix. Cell viability, material-mediated cytotoxicity, cellular proliferation, collagen production, GAG content, and mRNA gene expression patterns of the chondrocytes were evaluated. The cell viability and material-mediated cytotoxicity assay results show that the GAG/chitosan hydrogel has good biocompatibility. Chondrocytes cultured within the matrix had a slower proliferation but higher GAG production compared to those obtained for a monolayer culture. Real-time polymerase chain reaction results show that the mRNA expression of type II collagen was up-regulated but types I and X collagens were down-regulated. This study demonstrates that incorporating GAGs into a chitosan matrix maintains the normal phenotype of chondrocytes, making the GAG/chitosan matrix a candidate for MACI.

KW - Autologous chondrocyte implantation

KW - Chitosan hydrogel

KW - Chondrocyte

KW - Glycosaminoglycan

UR - http://www.scopus.com/inward/record.url?scp=84903775820&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903775820&partnerID=8YFLogxK

U2 - 10.5405/jmbe.1516

DO - 10.5405/jmbe.1516

M3 - Article

VL - 34

SP - 211

EP - 217

JO - Journal of Medical and Biological Engineering

JF - Journal of Medical and Biological Engineering

SN - 1609-0985

IS - 3

ER -